John Pfeifer Selected Research

2-amino-4-picoline

6/2012

Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Pfeifer Research Topics

Disease

6	Neoplasms (Cancer) 11/2021 - 11/2010
1	Pleuropulmonary blastoma 11/2021
1	Microsatellite Instability 01/2020
1	Sarcopenia 01/2018
1	Urinary Retention 01/2018
1	Breast Neoplasms (Breast Cancer) 10/2017
1	Thrombosis (Thrombus) 07/2015
1	Fistula 07/2015
1	Infections 11/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2012
1	Pneumonia (Pneumonitis) 06/2012
1	Neoplasm Metastasis (Metastasis) 05/2012
1	Adenocarcinoma of Lung 05/2012
1	Adenocarcinoma 05/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2012
1	Lung Neoplasms (Lung Cancer) 05/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2010
1	Ovarian Neoplasms (Ovarian Cancer) 06/2008

Drug/Important Bio-Agent (IBA)

2	Formaldehyde (Formol)FDA Link 01/2019 - 11/2010
2	ParaffinIBA 01/2019 - 11/2010
2	MicroRNAs (MicroRNA)IBA 05/2012 - 11/2010
1	B7-H1 AntigenIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Circulating Tumor DNAIBA 10/2017
1	neratinibIBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2015
1	2-amino-4-picolineIBA 06/2012
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	Deubiquitinating EnzymesIBA 06/2008
1	RNA (Ribonucleic Acid)IBA 06/2008

Therapy/Procedure

2	Therapeutics 01/2020 - 09/2012
1	Immunotherapy 01/2020
1	Length of Stay 01/2018
1	Peritoneal Dialysis 07/2015
1	Renal Dialysis (Hemodialysis) 07/2015
1	Patient Readmission 11/2013
1	Radiotherapy 09/2012